These findings validate the MMP3 activity as a serum marker to increase the diagnostic sensitivity for NPC, and indicate that the serum MMP3 activity and the EBV antibody combined have a better diagnosis values for screening NPC than traditional EBV antibody combined diagnosis. Here, MMP3 is linked to nasopharyngeal carcinoma.